Immunovant Inc. (IMVT) at a glance

Immunovant Inc. (IMVT) is a mid-cap Healthcare company. It trades at $36.83, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 53/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Value (40/100). Its volatility is roughly in line with the market.

Price
$36.83
Market cap
$6.90B
P/E ratio
n/a
Dividend yield
None
Beta
0.79
52-week range
$14.47 to $45.42
Vestovix Score53/ 100How this works
Value
40
Growth
50
Income
40
Safety
80
Momentum
66

Other Healthcare stocks

See all